Key result
The LPLS447X truncation variant enhanced receptor-mediated uptake of lipoproteins by hepatic cells compared to wild-type LPL, while showing no difference in catalytic activity or inhibition by ANGPTL4.
Why the study?
Does the LPLS447X variant improve lipoprotein uptake or catalytic activity compared to wild-type LPL in vitro?
Does the LPLS447X variant improve lipoprotein uptake or catalytic activity compared to wild-type LPL in vitro?
Answers are grounded in this paper and cite their sources.
The cardioprotective LPLS447X variant does not have altered catalytic activity but enhances receptor-mediated hepatic uptake of lipoproteins, providing a mechanistic explanation for its beneficial lipid profile.
Lipoprotein lipase (LPL) is responsible for the hydrolysis of triglycerides from circulating lipoproteins. Whereas most identified mutations in the LPL gene are deleterious, one mutation, LPL S447X, causes a gain of function. This mutation truncates two amino acids from LPL’s C-terminus. Carriers of LPL S447X have decreased VLDL levels and increased HDL levels, a cardioprotective phenotype. LPL S447X is used in Alipogene tiparvovec, the gene therapy product for individuals with familial LPL deficiency. It is unclear why LPL S447X results in a serum lipid profile more favorable than that of LPL. In vitro reports vary as to whether LPL S447X is more active than LPL. We report a comprehensive, biochemical comparison of purified LPL S447X and LPL dimers. We found no difference in specific activity on synthetic and natural substrates. We also did not observe a difference in the K i for ANGPTL4 inhibition of LPL S447X relative to that of LPL. Finally, we analyzed LPL-mediated uptake of fluorescently labeled lipoprotein particles and found that LPL S447X enhanced lipoprotein uptake to a greater degree than LPL did. An LPL structural model suggests that the LPL S447X truncation exposes residues implicated in LPL binding to uptake receptors.
No takes yet. Share an insight, caveat, or question.
Hayne et al. (2016) studied Lipoprotein lipase function. LPLS447X variant vs. Wild-type LPL was evaluated on Lipoprotein uptake by hepatic cells (p=<0.05). The LPLS447X truncation variant enhanced receptor-mediated uptake of lipoproteins by hepatic cells compared to wild-type LPL, while showing no difference in catalytic activity or inhibition by ANGPTL4.
Synapse has enriched 10 related papers. Consider them for comparative context: